Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 46

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 46
---
 trading days following the date of exercise (subject to the ‘cashless
exercise’ arrangements described below).

Cashless Exercise. If,
following the date that is six months from the initial issuance date of the warrant, a registration statement registering the issuance
of the securities underlying the warrants under the Securities Act is not then effective, or the prospectus contained therein is not
available for the resale of the securities issuable upon exercise of the applicable warrants, then in lieu of making the cash payment
otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to
receive upon such exercise (either in whole or in part) the net number of Depositary Shares determined according to a formula set forth
in the warrants.

Exercise Price.The exercise
price of each Series J Warrant and July 2024 Placement Agent Warrant is
$250.00 per Depositary Share and $312.50 per Depositary Share, respectively.

Beneficial Ownership Limitation. A
holder shall have no right to exercise any portion of a warrant, to the extent that, after giving effect to such exercise, such holder,
together with such holder’s affiliates, and any persons acting as a group together with such holder or any such affiliate, would
beneficially own in excess of 9.99% or 4.99%, at the holders determination, of the number of Ordinary Shares outstanding immediately
after giving effect to the issuance of the Ordinary Shares underlying the Depositary Shares upon such exercise. The holder of the warrant,
upon notice to us, may increase or decrease the beneficial ownership limitation to a percentage not to exceed 9.99%, provided that any
increase in the beneficial ownership limitation shall not be effective until 61 days following notice to us. Beneficial ownership of
the holder and its affiliates will be determined in accordance with Section 13(d) of the Exchange Act, and the rules and regulations
promulgated thereunder.

Stock dividends and stock splits. If
we pay a stock dividend or otherwise make a distribution payable in Depositary Shares or Ordinary Shares, or any other equity or equivalent
securities, subdivide or combine outstanding Depositary Shares or Ordinary Shares, or reclassify Depositary Shares, Ordinary Shares or
any shares of our capital stock, the exercise price of each warrant will be adjusted by multiplying the then exercise price by a fraction,
the numerator of which shall be the number of Depositary Shares (excluding treasury shares, if any) outstanding immediately before such